Xlife Sciences with significant progress in H1 2023 - adhoc

Xlife Sciences AG Key word Half Year Results Xlife Sciences with significant progress in H1 2023 21Sep2023 0700 CETCEST Release of an ad hoc announcement pursuant to Art 53 LR The issuer is solely re

Related Keywords

United States , China , Abu Dhabi , Abuz Aby , United Arab Emirates , Germany , Oliverr Baumann , Axenoll Life Sciences , Department Of Health , Drug Administration , Department Of Neurology Universit , Xlife Sciences , European Patent Office , Cantonal Hospital Aarau , Prostate Carcinoma , Life Sciences , Key Figures , Xlife Science , Laxxon Medical , Shareholders Meeting , Year Report , Ouxlife , Ciences , Results , Significant , Progress , Etcest , Release , Announcement , Ursuant , Ssuer , Olely , Esponsible , Content , Oday , Eported , Perational , Published , Financial , Figures , Reporting , ,